MedPath

WEZLANA I.V.

WEZLANA I.V.

Approved
DIN Number

02544210

Drug Class

Human

Market Date

Mar 1, 2024

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02544210
AIG Number0152506002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC05 USTEKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification90:24.20.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

USTEKINUMABActive
Strength: 5 MG / ML
Monograph: USTEKINUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.